DVYSR — Devyser Diagnostics AB Share News
0.000.00%
Last trade - 00:00- SEK844.49m
- SEK809.29m
- SEK250.50m
Brief: Devyser Q1 Sales SEK 54.8 Million
Brief: Devyser Secures Tender Worth SEK 61.8 Mln
Brief: Devyser Appoints Jan Wahlström As New CEO
Brief: Devyser Genomic Laboratories Gets Accreditation From College Of American Pathologists
Brief: Devyser Secures SEK 16.8 Mln Tender In Italy
Brief: Devyser Q4 Sales SEK 64.2 Million
Brief: Devyser Diagnostics Is Not Proposing Dividend For 2024
Brief: CEO Leaves Devyser
Brief: Devyser Preliminary Q4 EBIT Turns To Profit Of SEK 0.7 Mln
Brief: Devyser Achieves Class D Ivdr Approval For RHD Product
Brief: Devyser Says Is Confident In Reaching Financial Targets
Brief: Devyser Q3 Sales SEK 48.7 Million
Brief: Devyser Seeks To Secure FDA Approval
Brief: Devyser Compact Achieves Class III Approval In China
Brief: Devyser Q2 Sales SEK 53.2 Million
Brief: Devyser Wins Tender In Italy
Brief: Devyser Wins Tender Worth Up To SEK 8.4 Million
Brief: Devyser Expands Commercial Agreement With Thermo Fisher Scientific
Brief: Devyser Diagnostics Gets Tender For Up To SEK 75 Mln